Advertisement

Digestive Diseases and Sciences

, Volume 64, Issue 1, pp 281–282 | Cite as

Risk of Rebleeding After Hemostasis for Peptic Ulcer

  • Antonio PonzettoEmail author
  • John Holton
Correspondence

Dear Sir,

The important observation by Kondo et al. [1] reports the high risk of rebleeding after hemostasis of peptic ulcer. They analyze the risk factors and find that a high dose of steroids is an important one [1]. We concur; however, we believe a further risk factor should also be analyzed, i.e., the presence or not of Helicobacter pylori infection; indeed, Asaka et al. [2] reported a 66% rate of rebleeding due to peptic ulcer (PU) in Japanese patients who failed to eradicate this bacterium. We and others in Italy found that rebleeding was very rare after successful cure of H. pylori [3, 4]. One important observation is that during the acute phase of PU bleeding very often gastric biopsies lead to a false negative for the presence of H. pylori, as clearly stated by the Maastricht V/Florence consensus report [5]. This observation highlights the need for multiple tests for the detection of this bacterium in all patients, but more so in the bleeding ones [5]. Recently, Takatori et...

Notes

Author’s contribution

AP conceived the writing, and all authors contributed to the completion and approval of the letter.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Kondo Y, Hatta W, Koike T, et al. The use of higher dose steroids increases the risk of rebleeding after endoscopic hemostasis for peptic ulcer bleeding. Dig Dis Sci. 2018;63:3033–3040.  https://doi.org/10.1007/s10620-018-5209-y.CrossRefPubMedGoogle Scholar
  2. 2.
    Asaka M, Kato M, Sugiyama T, et al. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. J Gastroenterol. 2003;38:339–347.CrossRefGoogle Scholar
  3. 3.
    Ponzetto A, Pellicano R, Palmas F, Demarchi B, Rizzetto M. Cigarette smokers and non smokers suffer of duodenal ulcer relapse rarely after cure of Helicobacter pylori infection. Eur J Internal Med. 1997;8:131–133.Google Scholar
  4. 4.
    Capurso G, Annibale B, Osborn J, et al. Occurrence and relapse of bleeding from duodenal ulcer: respective roles of acid secretion and Helicobacter pylori infection. Aliment Pharmacol Ther. 2001;15:821–829.CrossRefGoogle Scholar
  5. 5.
    Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report. Gut. 2017;66:6–30.CrossRefGoogle Scholar
  6. 6.
    Takatori Y, Kato M, Sunata Y, et al. The role of history of gastro-duodenal ulcer in patients with upper gastrointestinal bleeding. Dig Dis. 2018;36:177–181.CrossRefGoogle Scholar
  7. 7.
    Tang Y, Shen J, Zhang F, Zhou X, Tang Z, You T. Scoring systems used to predict mortality in patients with acute upper gastrointestinal bleeding in the ED. Am J Emerg Med. 2018;36:27–32.CrossRefGoogle Scholar
  8. 8.
    Choe JW, Kim SY, Hyun JJ, et al. Is the AIMS 65 score useful in predicting clinical outcomes in korean patients with variceal and nonvariceal upper gastrointestinal bleeding? Gut Liver. 2017;11:813–820.CrossRefGoogle Scholar
  9. 9.
    Stanley AJ, Laine L, Dalton H, et al. for the International Gastrointestinal Bleeding Consortium. Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study. BMJ. 2017;356:i6432.  https://doi.org/10.1136/bmj.i6432.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Schilling D, Demel A, Nusse T, Weidmann E, Riemann JF. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial. Endoscopy. 2003;35:393–396.CrossRefGoogle Scholar
  11. 11.
    Park SJ, Park H, Lee YC, et al. Effect of scheduled second-look endoscopy on peptic ulcer bleeding: a prospective randomized multicenter trial. Gastrointest Endosc. 2018;87:457–465.CrossRefGoogle Scholar
  12. 12.
    Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E, Dominguez-Munoz JE. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst Rev. 2004:CD004062.Google Scholar
  13. 13.
    Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ, Lin JT. Long-term peptic ulcer rebleeding risk estimation in patients undergoing haemodialysis: a 10-year nationwide cohort study. Gut. 2011;60:1038–1042.CrossRefGoogle Scholar
  14. 14.
    Wong GL, Wong VW, Chan Y, et al. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology. 2009;137:525–531.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Medical SciencesUniversity of TurinTurinItaly
  2. 2.National Mycobacterial Reference Unit National Mycobacterium Reference Laboratory (NMRL) Abernethy BuildingInstitute of Cell and Molecular Science (ICMS)LondonUK

Personalised recommendations